SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-21-000176
Filing Date
2021-08-09
Accepted
2021-08-09 07:01:49
Documents
65
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sesn-20210630.htm   iXBRL 10-Q 1294619
2 EX-31.1 sesn-06302021x10qex311.htm EX-31.1 11744
3 EX-31.2 sesn-06302021x10qex312.htm EX-31.2 11669
4 EX-32.1 sesn-06302021x10qex321.htm EX-32.1 6229
5 EX-32.2 sesn-06302021x10qex322.htm EX-32.2 6193
  Complete submission text file 0001485003-21-000176.txt   6092271

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20210630.xsd EX-101.SCH 46704
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sesn-20210630_cal.xml EX-101.CAL 46400
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sesn-20210630_def.xml EX-101.DEF 201769
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20210630_lab.xml EX-101.LAB 556450
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20210630_pre.xml EX-101.PRE 349513
11 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20210630_htm.xml XML 956080
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 211154573
SIC: 2834 Pharmaceutical Preparations